轻度认知功能障碍筛查量表研究进展

轻度认知功能障碍(MCI)患者是老年性痴呆(SD)的高危人群。痴呆的发病率随着世界人口老龄化的加剧而迅速攀升,中晚期痴呆的治疗效果欠佳,而对MCI的早期筛查和干预可延缓痴呆病程的进展。文中对国内外MCI筛查量表的研究分析得出,记忆与执行筛查(MES)量表、Dem Tect、中文修订版轻度认知功能障碍测试(CAMCI)和阿尔茨海默病调查问卷(AQ)4种筛查量表可作为MCI筛查的首选筛查量表。     

蒙特利尔认知评估量表在轻度认知功能障碍筛查中的应用

目的 探讨蒙特利尔认知评估量表(MoCA)在轻度认知功能障碍(MCI)患者筛查中的应用.方法 应用简易精神状态检查量表(MMSE)、MoCA对32例MCI患者和50例健康对照者进行神经心理评估,比较二者筛查MCI的效果.结果 以26分为分界值,MoCA筛查MCI的敏感性为96.87%、特异性为76%,MMSE筛查MCI的敏感性为56.25%、特异性为96%;MoCA中除抽象思维、地点定向两项外,其余各亚项的评分在MCI组和对照组间差异均有统计学意义(P＜0.05):MMSE中仅计算与注意力、延迟回忆两项在MCI组和对照组间差异有统计学意义(P＜0.05),其余各项差异均无统计学意义(P＞0.05).结论 MoCA为高敏感性的MCI筛查工具,能全面评估MCI患者的认知功能.且可用于筛查MMSE得分正常的MCI患者.     

神经心理学量表在轻度认知功能障碍筛查中的应用

随着中国老龄化程度的不断加深,痴呆发病率逐年上升,严重危害着人民健康,并带来了巨大的社会和经济负担.2020 年发表的一项全国性横断面研究数据显示,中国 60 岁及以上人群中约有 1507 万痴呆患者,轻度认知功能障碍(mild cogni-tive impairment,MCI)的患病率约为15. 5％,患者数达38...     

蒙特利尔认知评估量表和简易精神状态量表在帕金森病轻度认知功能障碍筛查中的应用

目的探讨蒙特利尔认知评估量表(MOCA)和简易精神状态量表(MMSE)在帕金森病轻度认知功能障碍(PDMCI)筛查中的应用。方法采用随机抽样方法,应用MOCA和MMSE对75例诊断为PDMCI患者、帕金森病认知功能正常(PDN)患者180例和健康患者145例进行评估,比较二者筛查PDMCI的敏感性和特异性。结果在文盲组MMSE的敏感性为93.10%,特异性为100%,而MOCA的敏感性仅为0%,特异性为92.72%;在小学组MMSE的敏感性为87.50%,特异性为100%,而MOCA的敏感性为41.67%,特异性为79.17%;在初中及以上学历组MMSE的敏感性为27.27%,特异性为100%,MOCA的敏感性为90.91%,特异性为85.71%。结论 MOCA适合初中及以上学历的PDMCI筛查工具,MMSE适合初中以下学历PDMCI筛查工具。     

轻度认知功能障碍和轻度阿尔茨海默病患者的选择注意功能的研究

目的 了解轻度认知功能障碍(mild cognitive impairment,MCI)患者和轻度阿尔茨海默病(Alzheimer's disease,AD)患者的选择注意功能。方法 采用斯特鲁普(Stroop)测验对15例符合国际精神疾病分类第10版(ICD-10)及美国神经病学、语言障碍和卒中/老年性痴呆和相关疾病学会(NINCDs/ADRDA)标准的轻度AD患者、15例MCI患者和15例正常老年人进行对照研究。结果 冲突条件下轻度AD患者表现出更大的干扰效应,犯错误更多,反应时间也趋向于更长,MCI组和正常对照组干扰量无明显差别,但MCI组总错误率明显高于正常对照组。结论 轻度AD患者存在选择注意功能障碍,MCI患者选择注意功能下降,介于健康老人和轻度AD患者之间。     

外周血Klotho蛋白和mRNA对老年AD和MCI患者认知功能障碍的预测价值研究

目的 探究外周血Klotho蛋白和mRNA对老年阿尔茨海默病(AD)和轻度认知功能障碍(MCI)患者认知功能障碍的预测价值。方法 选取2021年2月至2022年4月新疆医科大学第一附属医院老年病科收治的160例患者为研究对象,其中AD组40例,MCI组40例,对照组80例。使用ELISA和qRT-PCR检测三组的Klotho蛋白和mRNA表达。分析Klotho蛋白和mRNA表达在三组人群中的差异。多因素Logistic回归分析AD、MCI患者患病相关影响因素。受试者工作特征(ROC)曲线分析外周血Klotho蛋白和mRNA对老年认知功能障碍的预测价值。结果 AD组、MCI组Klotho mRNA表达均低于对照组(P<0.05),MCI组Klotho蛋白表达低于对照组(P <0.05)。年龄和Klotho mRNA是AD的影响因素(OR=1.077、0.366,P<0.05)。Klotho蛋白和Klotho mRNA是MCI的影响因素(OR=0.598、0.110,P<0.05)。ROC曲线显示,Klotho蛋白、Klotho mRNA及两项指标联合预测AD、MC...     

中文修订版智能筛查检测在阿尔茨海默病和轻度认知损害评估中的作用

目的:探讨智能筛查测验(CASI)在不同严重度的阿尔茨海默病(AD)患者中的表现及与MMSE总分的关系。方法:使用2.0版本的CASI、MMSE及临床痴呆量表等对30名正常中老年人、20例轻度认知损害(MCI)和53例不同严重度的AD患者(20例轻度、19例中度、14例重度)进行评估。结果:根据CASI因子分分析发现,MCI组新记忆和概念判断受损、完成测验的耗时数延长,AD组在从轻至重度组中依次出现定向障碍、心算障碍,直到所有因子分均显著减退。除"概判"因子外,其余因子分都随着病情严重度而逐渐降低。除了重度AD组以外,MCI组、轻度AD组和中度AD组均较前一组下降约10分。CASI总分以≤85分为界:识别MCI的敏感度为70.6%;识别轻度AD的敏感度为82.7%;特异度均为73.9%。对于大学及以上文化者,CASI难度过低,容易出现假阴性。结论:CASI可有效判断AD认知损害的严重度,并能从组成项目中获得MMSE总分。     

蒙特利尔认知评估量表在轻度认知功能障碍中的应用

目的探讨蒙特利尔认知评估量表在轻度认知功能障碍患者中的应用。方法测试年龄及教育程度相匹配的42例MCI患者及39例正常对照组进行MoCA测查。结果与对照组（27.36±1.38）相比,MCI组的MoCA总分（23.93±3.69）更差,差异有统计学意义（P〈0.01）;MCI组在命名、语言及定向方面与对照组无明显差异（P〉0.05）。MCI组在视空间与执行功能（HC 4.46±0.78,MCI 3.57±1.23）、注意（HC 5.95±0.22,MCI 5.61±0.73）、抽象思维（HC 1.61±0.54,MCI1.21±0.68）及延迟回忆（HC 3.54±0.88,MCI 1.97±1.20）方面,均较对照组更差,差异有统计学意义（P〈0.01）。结论MCI患者不仅在记忆上较正常人差,可能在视空间与执行功能、注意、抽象思维方面存在损害。MoCA量表对MCI患者各认知方面可起到初筛作用。     

轻度认知功能障碍的遗传学研究进展

轻度认知功能障碍(MCI)在老年人群非常普遍。遗传学研究作为研究MCI诊断和预测的方法能提供很有价值的线索。虽然我们对MCI进展为AD现有的相关遗传学知识了解有限,但仍有足够的机会去研究和发现。本文就目前MCI的相关热点致病基因进行综述,并探讨了基因研究中存在的一些问题以及今后发展的方向。     

脑干听觉反应在轻度认知功能障碍老年人和阿尔茨海默病中的应用

目的探讨轻度认知功能障碍老年人(MCI)和阿尔茨海默病(AD)在脑干听觉反应(ABR)检测中的特点,为早期痴呆的诊断提供帮助.方法应用美国Nicolet Bravo脑电生理仪及Click短声刺激,测查36例MCI和30例阿尔茨海默病(AD)和45名健康老人(NC)的ABR.结果 MCI组、AD组及NC组在绝对潜伏期波Ⅲ(Pz脑区),绝对波幅波Ⅲ(Pz脑区),波V(Pz脑区)上有差异极显著性(P＜0.01).与NC组和MCI组相比,绝对潜伏期波Ⅲ(Pz脑区)上,AD组延迟于NC组和MCI组(P＜0.01).波幅分析所见,绝对波幅波Ⅲ(Pz脑区)和绝对波幅波V(Pz脑区)AD组低于NC组和MCI组.MCI组与NC组比较,差异有显著性(P＜0.05).结论 ABR对临床辅助诊断AD和MCI有参考价值.     

Subjective rating of executive functions in mild Alzheimer's disease

Objectives: Subjective cognitive decline is considered to be a core feature of pre-Alzheimer's disease (AD) conditions, the vast majority of literature having focused on memory concerns. Neuropsychological studies have implicated executive dysfunction on objective performance measures in AD, but no research has evaluated whether individuals with AD have concerns about their executive functions and whether it differs from their caregiver's concerns. In the present study, we sought to evaluate self- and informant ratings of executive functioning in patients with mild AD.

Method: Participants were 23 patients with mild AD and 32 healthy elderly controls (HC) and their informants who completed the Behavior Rating Inventory of Executive Function – Adult version.

Results: Patients with AD and their informants reported greater executive dysfunction than the HC group and their informants, respectively, and patients reported greater difficulty than their informants. The largest effect size for both self- and informant ratings was obtained for the Working Memory scale.

Conclusions: These findings indicate that subjective cognitive concerns in mild AD extend beyond the memory domain to executive functions. That greater difficulty was endorsed by patients than their informants suggests that at least in the mild stage of AD some awareness of executive dysfunction may be maintained in some patients. Implications for clinical care are discussed.     

Subclinical epileptiform activity during sleep in Alzheimer's disease and mild cognitive impairment

ObjectiveRecent findings suggested that subclinical epileptiform activity is prevalent during sleep in a significant proportion of Alzheimer’s Disease (AD) patients. The aims of our study were: (A) comparing the frequency of subclinical epileptiform activity during the sleep in a sample diagnosed with ‘probable’ AD and Mild Cognitive Impairment (MCI) due to AD, and in healthy subjects; (B) evaluating epileptiform EEG activity as a function of different sleep stages within a well-controlled polysomnographic setting.MethodsWe prospectively enrolled 50 ‘probable’ AD patients (73 ± 7.0 years) and 50 subjects with MCI due to AD (72 ± 6.7 years) without history of seizures, comparing them with 50 controls (69 ± 6.7 years). Patients underwent to a full-night video-PSG.ResultsSubclinical epileptiform activity was detected in 6.38% of ‘probable’ AD patients, 11.63% of MCI due to AD subjects and 4.54% of controls (p = 0.43). The comparisons between the three groups for the frequency of epileptiform activity did not reach statistically significant differences neither for total sleep nor for any sleep period considered.ConclusionsOur study shows that, when controlling for sleep stages and the influence of psychoactive drugs, AD patients and MCI due to AD subjects do not exhibit a higher frequency of epileptiform discharges during sleep compared to healthy subjects.SignificanceSubclinical epileptiform activity during sleep does not discriminate ‘probable’ AD from MCI due to AD and healthy controls.     

事件相关电位在轻度认知功能障碍诊断中的意义

目的探讨轻度认知功能障碍和阿尓茨篋〉氖录喙氐缥?ERP:N100、P300)变化。方法根据Peterson制订的MCI诊断标准,筛选出21例MCI患者(MCI组),22例正常对照者(NC组)以及20例阿尓茨篋?AD)组患者,分别用英国OXFORD脑电生理仪记录事件相关电位(ERP:N100,P300)和视觉诱发电位(VEP)情况。结果(1)AD组MMSE评分(16.52±2.17分)及MCI组(24.33±1.34分)低于正常对照组[(26.57±1.43)分,P<0.01]。(2)AD组与MCI组靶波幅P3和非靶波幅P2均见降低,与NC组比较也有显著性差异(P<0.05、P<0.01)。(3)N100潜伏期、波幅变化不是很大(P>0.05)。(4)AD组P300靶刺激中的P2、P3波潜伏期与MMSE分值呈负相关(P<0.05、P<0.01)。结论AD和MCI患者的P300有多项指标异常对于临床诊断AD和MCI患者有一定价值。事件相关电位与认知功能存在明显相关性,提示事件相关电位可以客观反映AD和MCI患者的认知功能障碍。     

Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease

OBJECTIVES: To investigate the correlation between anosognosia and behavioural symptoms, performance on executive tests, and frontal cortex regional cerebral blood flow (rCBF) in patients with 'amnestic mild cognitive impairment' (MCI) and mild Alzheimer's disease (AD). METHODS: From a prospective Memory Clinic cohort including consecutively referred patients, age 60 years or above, and with MMSE score 20 or above, 36 patients with AD and 30 with MCI were included in this study. Anosognosia was assessed using a categorical scale and discrepancy scores between patients' and relatives' reports on a 20-item Memory Questionnaire (MQ). Behavioural symptoms were assessed with Frontal Behavioural Inventory (FBI). Executive functions were examined with a range of neuropsychological tests. Tc99m-HMPAO SPECT was obtained in an unselected sample of 55 of the 66 patients, and rCBF was analysed in six cortical frontal regions. RESULTS: Insight was equally impaired in the two patient groups. A significant correlation was found between impaired awareness and dementia severity (MMSE). Discrepancy-scores on the MQ were significantly correlated to scores on FBI and to rCBF in the right inferior frontal gyrus, but not to executive tests. The groups classified by the categorical ratings 'full', 'shallow' and 'no' awareness were not characterized by differences in behavioural symptoms, executive performance or frontal rCBF. CONCLUSIONS: Impaired awareness is associated with behavioural symptoms and may reflect functional impairment in the right inferior frontal cortex.     

血清BDNF与尿AD7c-NTP联合检测在MCI进展为AD中的预测价值

目的探讨血清BDNF与尿AD7c-NTP联合检测对轻度认知功能障碍(MCI)进展为阿尔茨海默病的预测价值。方法收集172例MCI患者(MCI组)及90例健康者(正常对照组)基线、12 m、24 m的血清BDNF和尿AD7c-NTP的表达水平。结果 MCI患者血清BDNF水平在基线、12 m、24 m显著低于同期对照组(P0.05),而尿AD7c-NTP水平在基线、12 m、24 m显著高于同期对照组(P0.01)。此外,32例MCI患者于随访的2y中进展为AD(MCI-AD组),其血清BDNF水平在基线、12 m、24 m显著低于稳定型MCI患者(MCI-ST组),而尿AD7c-NTP水平在基线、12 m、24 m显著高于稳定型MCI患者。结论血清BDNF与尿AD7c-NTP联合检测是鉴别及诊断MCI进展为AD的较好指标,提升二者单独应用时的预测价值。     

Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration

BACKGROUND: Mild Cognitive Impairment defines a transitional stage between normal ageing and dementia, and reflects the clinical situation where a person has memory complaints and objective evidence of cognitive impairment but no evidence of dementia. To plan the care of patients with MCI, it is important to predict as accurately as possible potential risk factors modulating the conversion to AD. AIM: To investigate the risk factors associated of conversion to dementia of Alzheimer type (AD) for subjects with amnestic Mild Cognitive Impairment (aMCI). METHODS AND MATERIALS: One hundred nineteen subjects consecutively recruited who met the operational criteria for aMCI (with or without deficits in other cognitive domains). They underwent multidimensional assessment and a neuropsychological battery at baseline and at follow-up, after 1 year. Diagnosis for dementia was based on a deficit in two or more cognitive domains severe enough to affect the participant functional abilities. Subjects converted to AD over time were classified as Demented; subjects that remained unchanged, or became cognitively normal during follow-up, were defined as Stable. RESULTS: Demented MCI (N = 40; 33.6%) were older (mean age 73.5 +/- 8.5 vs. 69.2 +/- 7.0; p = 0.006) when compared to Stable (N = 79; 66.4) and their global cognitive performances, at baseline, were more compromised when assessed by ADAS-Cog (mean score 10.7 +/- 3.9 vs 6.7 +/- 3.4; p = .000) and by MMSE (mean score 26.1 +/- 1.9 vs. 27.3 +/- 1.8; p = 0.002). Demented were similarly compromised in basic activities of daily living (BADL mean 0.2 +/- 0.4 vs 0.1 +/- 0.3 functions lost; p = NS) but more compromised on instrumental daily functions (IADL mean 0.7 +/- 0.8 vs. 0.1 +/- 0.5 functions lost; p = 0.001). The presence of white matter lesions (WML) on CT or MRI was more pronounced in Demented group (p = 0.02). After 1 year; Demented worsened on phonemic verbal fluency (PFL) (p = 0.009), Raven's coloured matrices (p = 0.003), Trail Making test A and B (p = 0.008 and p = 0.007 respectively) and in Instrumental Activities of Daily Living (IADL) (p =0 .000) respect to Stable. Logistic regression analysis revealed that ADAS-Cog basal score, Trail Making B, IADL but not memory deterioration were significantly associated to the conversion to AD. CONCLUSIONS: In subjects with aMCI poor global cognitive performance at baseline, the worsening on executive functions and on functional status but not the worsening on memory functions are independently associated with the conversion to dementia of Alzheimer type at 1 year, follow-up.     

A longitudinal study regarding conversion from mild memory impairment to dementia in a Japanese community

OBJECTIVE: To estimate the rate that subjects with Mild Memory Impairment /Not Dementia (MMI/ND) shifted to dementia in a population-based cohort and to establish simple diagnostic methods for identification of high-risk persons for dementia. METHODS: Subjects in a community-based elderly cohort of MMI/ND were followed longitudinally. Subjects were selected from the participants in the first Nakayama study. MMI/ND was defined as memory deficit with objective memory assessment, without dementia, impairment of general cognitive function, or disability in activities of daily living. The conversion rate was calculated using the person-year method. RESULTS: At baseline, the sample consisted of 104 subjects (59 female; 45 male) selected from 1,162 community dwellers aged over 65 year. During the five-year follow-up, 14 subjects died, 13 moved to other communities, and six refused to participate further. Eleven (10.6%) subjects were diagnosed with Alzheimer's disease (AD), five (4.8%) were diagnosed with vascular dementia (VaD), and six (5.8%) were diagnosed with dementia of other etiology. The annual conversion rate that MMI/ND shifted to AD is calculated on 8.5% per 100 person-year, and shifted to dementia on 16.1% per 100 person-year in this survey. CONCLUSIONS: The rate at which subjects with MMI/ND whose conditions shifted to dementia was the same as the rate that subjects with mild cognitive impairment (MCI) shifted to dementia in a previous report. It would be useful to identify groups of high-risk individuals for dementia by simple diagnostic methods.